A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

AKH - Medical University of Vienna, Vienna

Edegem - UNIV UZ Antwerpen, Edegem

Hvidovre Hospital, Hvidovre

Hospital Ramón y Cajal, Madrid

Medizinische Hochschule Hannover, Hanover

HOP Rangueil, Toulouse

Rambam Medical Center, Haifa

Floridian Clinical Research-Miami Lakes-68368, Miami Lakes

Azienda Ospedaliera Policlinico di Modena, Modena

Ospedale Civile di Baggiovara, Baggiovara (MO)

Universitätsklinikum Münster, Münster

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

American Research Corporation, San Antonio

"Policlinico Paolo Giaccone", Palermo

California Liver Research Institute, Pasadena

HOP Beaujon, Clichy

Inland Empire Clinical Trials, LLC, Rialto

Beijing Friendship Hospital, Beijing

Singapore General Hospital, Singapore

Zhongshan Hospital Affiliated to Fudan University, Shanghai

The Affiliated Hospital of Hangzhou Normal University, Hangzhou

"Regional Institute of Gastroenterology Hepatology Prof. Dr. O. Fodor", Cluj-Napoca

NanFang Hosptial, Guangzhou

Western Galilee Hospital, Nahariya

Hospital Britanico de Buenos Aires, CABA

Hospital Italiano de Buenos Aires, CABA

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal

National Hospital Organization Yokohama Medical Center, Kanagawa, Yokohama

Osaka Metropolitan University Hospital, Osaka, Osaka

Amsterdam UMC, location VUMC, Amsterdam

Hospital Vall d'Hebron, Barcelona